| Ytd | -47.54% | |
| 1y | -63.50% |
| Open | 0.82 | Prev Close | 0.80 | Low | 0.80 | High | 0.97 | Mkt Cap | 15.56M |
| Vol | 993.84K | Avg Vol | 1.43M | EPS | -3.25 | P/E | -0.29 | Forward P/E | -4.89 |
| Beta | 3.02 | Short Ratio | 9.32 | Inst. Own | 100.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 0.58 | 200-d Avg | 1.20 | 1yr Est | 68.78 |
JSPR News
Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are
Jasper Therapeutics Inc. (NASDAQ:JSPR) on Thursday said it completed its all-stock acquisition of Ki
Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's
Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s
Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partner
Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper" or the "Company"), today announced
Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in
Gainers Exicure (NASDAQ:XCUR) stock rose 38.4% to $2.38 during Tuesday's after-market session.
Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular s
Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m
Major M&A deals this week include: New Mountail Capital buys Asset Living, SalesForce acquires C
Jasper Therapeutics (JSPR) appears to have found support after losing some value lately, as indicate
REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Ja
REDWOOD CITY, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jas
REDWOOD CITY, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (J
Pre-Market Stock Futures: Futures are trading higher after President Trump signalled that talks with
REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Ja
Jasper Therapeutics, Inc. (JSPR) Discusses Updated Data from BEACON and Open-Label Extension Studies
67% of additional patients (n=6) enrolled in the BEACON study achieved a complete response at 12 wee
Thomas Wiggans appointed Executive Chairperson Jasper to host an investor webinar on January 8 th a
Jasper Therapeutics, Inc. (NASDAQ: JSPR - Get Free Report)'s share price traded down 7.3% on Monday.
Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary
Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12
REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Ja
NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized sha
Shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR - Get Free Report) have received an average recomm
New York, New York--(Newsfile Corp. - November 18, 2025) - WHY: Rosen Law Firm, a global investor ri
LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors th
NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, L
Upgrades
On Thursday, 1076 companies hit new 52-week lows.
On Wednesday, 340 stocks hit new 52-week lows.
On Tuesday, 507 stocks hit new 52-week lows.
During Friday's session, 574 stocks hit new 52-week lows.
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 2
On Wednesday, 329 companies hit new 52-week lows.
Wednesday's session saw 269 companies set new 52-week lows.
On Friday, 431 companies hit new 52-week lows.
During Tuesday's session, 454 stocks hit new 52-week lows.